Liposomal Targeting Modifies Endosomal Escape: Design and Mechanistic Implications
Source abstract
Abstract
Development of effective targeted nanoparticle (TNP) therapeutics requires rational design of targeted and endosomolytic moieties. Nevertheless, endosomal escape of TNPs is poorly understood, relying on extrapolation of knowledge from nontargeted (NP) systems. Here, we describe how incorporation of targeting elements on endosomolytic nanoparticles alters the endosomal escape mechanism. We demonstrated that NP and TNP systems react differently to addition of precise length oligohistidines and showcase the effects of alternating spatial arrangements of targeting and endosomolytic elements. The results established that these elements act cooperatively and must be incorporated as individual moieties, rather than a single multifunctional moiety, for optimal internalization by target cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States
Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States
Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana 46556, United States
Berthiaume Institute for Precision Health, University of Notre Dame, Notre Dame, Indiana 46556, United States
Funding
Walther Cancer Foundation
References (34)
Show source-provided references
1. 10.3389/fphar.2018.0079010.3389/fphar.2018.00790 ↗
2. 10.1038/s41467-018-03705-y10.1038/s41467-018-03705-y ↗
3. 10.1016/j.tibtech.2016.07.00610.1016/j.tibtech.2016.07.006 ↗
4. 10.1126/science.122956810.1126/science.1229568 ↗
5. 10.1016/j.tibtech.2013.09.00710.1016/j.tibtech.2013.09.007 ↗
6. 10.1007/s00432-014-1767-310.1007/s00432-014-1767-3 ↗
7. 10.1021/acs.bioconjchem.8b0073210.1021/acs.bioconjchem.8b00732 ↗
8. 10.1016/j.addr.2007.06.00810.1016/j.addr.2007.06.008 ↗
9. 10.2217/nnm-2018-032610.2217/nnm-2018-0326 ↗
10. 10.1016/j.jconrel.2010.11.00410.1016/j.jconrel.2010.11.004 ↗
11. 10.1039/c2nr31064c10.1039/c2nr31064c ↗
12. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
13. 10.1038/nbt.261410.1038/nbt.2614 ↗
14. 10.1023/A:102221900355110.1023/A:1022219003551 ↗
15. 10.1016/j.nantod.2014.04.01110.1016/j.nantod.2014.04.011 ↗
16. 10.1101/cshperspect.a01698010.1101/cshperspect.a016980 ↗
17. 10.1016/j.ijpharm.2021.12055610.1016/j.ijpharm.2021.120556 ↗
18. 10.1016/j.biochi.2019.02.01210.1016/j.biochi.2019.02.012 ↗
19. 10.1021/acs.accounts.9b0017710.1021/acs.accounts.9b00177 ↗
20. 10.1007/s00018-006-6456-110.1007/s00018-006-6456-1 ↗
21. 10.1007/s00109-006-0119-410.1007/s00109-006-0119-4 ↗
22. 10.1021/bc100060910.1021/bc1000609 ↗
23. 10.1039/D1NR05357D10.1039/D1NR05357D ↗
24. 10.1021/nn305663e10.1021/nn305663e ↗
25. 10.1021/nn403395410.1021/nn4033954 ↗
26. 10.1039/C8NR09431D10.1039/C8NR09431D ↗
27. 10.1016/j.jconrel.2020.04.01010.1016/j.jconrel.2020.04.010 ↗
28. 10.1186/s13045-020-00965-410.1186/s13045-020-00965-4 ↗
29. 10.1021/jm020033k10.1021/jm020033k ↗
30. 10.1158/1535-7163.MCT-15-086710.1158/1535-7163.MCT-15-0867 ↗
31. 10.1016/j.jconrel.2019.08.03310.1016/j.jconrel.2019.08.033 ↗
32. 10.1002/smll.20180509710.1002/smll.201805097 ↗
33. 10.1016/j.actbio.2009.04.02110.1016/j.actbio.2009.04.021 ↗
34. 10.1073/pnas.150012811210.1073/pnas.1500128112 ↗